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New Saffold  
Cardiovirus in  
Children, China 
To the Editor: A new member of 
the genus Cardiovirus, termed Saffold 
virus  (SAFV), was discovered recent-
ly in stool specimens and nasopharyn-
geal aspirate samples from patients 
with fever of unknown origin, respi-
ratory symptoms, or gastroenteritis; 
these have been considered the first 
documented reports of cardiovirus 
infection in humans (1–4). However, 
the epidemiologic characteristics and 
pathogenic role of the virus are not 
fully understood.
From July 2006 through June 
2008, stool specimens were collected 
from 631 hospitalized children with 
diarrhea and 161 asymptomatic con-
trols in Lanzhou, People’s Republic of 
China. All children were <5 years of 
age (median age 8 months, range 0–60 
months). Diarrhea was defined as >3 
loose stools in the previous 24–72 h. 
Controls were asymptomatic children 
who had been brought to the First 
Hospital of Lanzhou University Pedi-
atric Primary Care Center for a routine 
checkup and had not had fever, diar-
rhea, vomiting, or a respiratory illness 
in the previous 3 weeks. The stool 
specimens were then transported to the 
Chinese Center for Disease Control 
and Prevention, Beijing, to undergo 
screening for common enteric viruses. 
The specimens were tested for rotavi-
rus by using a commercially available 
ELISA kit (IDEIA Rotavirus; DAKO, 
Glostrup, Denmark), and PCR and re-
verse transcription PCR (5) were used 
to screen for other common enteric vi-
ruses, including norovirus, sapovirus, 
astrovirus, and adenovirus.
Viral RNA and DNA were ex-
tracted from 140 µL of 10% fecal sus-
pension in phosphate-buffered saline 
by using QIAamp Viral RNA Mini Kit 
(QIAGEN, Hilden, Germany); viral 
RNA and DNA was supposed to be 
extracted simultaneously, according 
to the manufacturer’s instructions. Ex-
tracts of nucleic acid were tested for 
SAFV by a nested PCR that targeted 
the 5′ untranslated region (UTR) gene 
as described by Drexler et al. (4). 
The viral protein 1 (VP1) gene from 
positive samples was amplified as 
described by Chiu et al. (3). Positive 
bands were cloned and sequenced in 
both directions.
By confirming sequences of the 
5′ UTR gene, 3 (0.5%) specimens 
from the 631 children with diarrhea 
(LZ50419, LZ52903, LZ53879) and 
1 (0.6%) from the 161 asymptomatic 
children (LZ53010) were found to be 
positive for SAFV. Of the 4 positive 
specimens, 2 were collected in Octo-
ber, 1 in September, and 1 in June. The 
median age of the 4 patients with posi-
tive specimens was 6 months (range 
2–25 months). Viral co-infection was 
detected in the 3 children with diarrhea 
who had SAFV-positive specimens; 2 
were co-infected with rotavirus and 1 
with norovirus. No co-infection was 
detected in the asymptomatic child 
with SAFV-positive results. 
The 0.5% detection rate of SAFV 
in children with diarrhea in our study 
is lower than the 1.2% reported by 
Chiu et al. (3). One possible reason 
could be that the patients in our study 
were younger (median age 8 months), 
but in other studies, the median age 
was 20 months for all patients with 
confirmed cases. Nonetheless, the sea-
sonal distribution of the positive cases 
in our study is in accordance with the 
result of Drexler et al. (4), namely, in 
late summer and early fall.
The 5′ UTR sequences of the 4 
positive samples were deposited in 
GenBank (accession nos. FJ586238, 
FJ586239, FJ610244, and FJ623968). 
After several trials, only the VP1 se-
quence of sample LZ50419 was am-
plified (accession no. FJ586240). The 
obtained sequences were analyzed 
by using the DNASTAR software 
package (DNASTAR, Madison, WI, 
USA). A BLAST search (http://blast.
ncbi.nlm.nih.gov/Blast.cgi) demon-
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strated that that 5′ UTR sequences of 
the 4 positive samples— LZ50419, 
LZ52903, LZ53010, and LZ53879—
had nucleotide identity of 96%, 91%, 
96%, and 95% to the SAFV proto-
type strains (SAFV 1 California/81, 
EF165067.2), respectively; the VP1 
sequence of sample LZ50419 had a 
nucleotide identity of 87% and amino 
acid identity of 97% with the SAFV1 
California/81. Phylogenetic analysis 
(Figure) showed that the SAFV found 
in China clustered with the strain iso-
lated in the United States in 1981. This 
finding suggests that the 1981 VP1 lin-
eage was still circulating. More study 
is needed to address genetic variation 
of this lineage.
Our finding of SAFV in children 
hospitalized with diarrhea in China 
suggests that the virus is distributed 
worldwide. The detection of the virus 
in the asymptomatic control in our 
study is also noteworthy. Fisher exact 
test results showed no significant dif-
ference in the detection rate between 
the case group and the control group. 
The concurrent detection of SAFV 
and other enteric viruses raises con-
cern over a causative role of SAFV 
in human gastroenteritis. The current 
study does not suggest that SAFV has 
any association with acute enteritis 
based on a statistical analysis. Also, as 
with several other novel viruses dis-
covered recently, SAFV has not been 
associated with any clinically relevant 
disease in humans, although it has 
been isolated from cell cultures (4). 
Thus, we presume that SAFV is only a 
gastroenteric passenger because most 
picornaviruses are associated with 
enteric infection and with a known 
fecal–oral route of transmission. More 
comprehensive studies are needed to 
ascertain whether SAFV has any clini-
cal relevance.
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Figure. Phylogenetic relationships of deduced partial viral protein 1 amino acid sequences. 
Phylogenetic analyses using MEGA version 3.1 (www.megasoftware.net) and the 
neighbor-joining algorithm calculated by the Poisson correction model were based on 
alignment of 289 amino acids. The new strain from this study is shown in boldface. The 
scale bar indicates the genetic distance of 0.05 substitution/site. SAFV, Saffold virus; 
TMEV, Theiler’s murine encephalomyelitis virus; TRV, Thera virus; VHEV, Vilyuisk human 
encephalomyelitis virus.
